Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response  by Fiser, Steven M. et al.
ated with the need for prolonged intensive care and
increased mortality.6-8 Although ischemia is clearly
involved, it has become increasingly evident that reper-
fusion is responsible for the majority of injury after
lung transplantation.9 In addition, studies have con-
firmed that the lung injury is a result of up-regulation of
inflammatory mediators after reperfusion.10,11
Neutrophils have long been recognized as critical com-
ponents of the inflammatory cascade, but their role in the
pathophysiology of lung reperfusion injury has been a
source of controversy. Evidence that neutrophils play an
important role in lung reperfusion injury has been shown
in recent investigations using leukocyte depletion and in
studies with monoclonal antibodies directed against adhe-
sion molecules on leukocytes and endothelial cells.2,9-14
In contrast, some investigators have demonstrated that
significant reperfusion injury can occur without neu-
trophil participation and that neutrophils may have no
effect at all in some models of lung reperfusion injury.15,16
D espite considerable advancements in organ preser-vation techniques and solutions, transplanted lungs
remain vulnerable to reperfusion injury, with severe
graft dysfunction occurring in 20% of lung transplant
recipients.1-5 Severe graft dysfunction after lung trans-
plantation can be reversible; however, it is often associ-
Objective: Both donor pulmonary macrophages and recipient circulating
leukocytes may be involved in reperfusion injury after lung transplantation.
By using the macrophage inhibitor gadolinium chloride and leukocyte filters,
we attempted to identify the roles of these two populations of cells in lung
transplant reperfusion injury.
Methods: With our isolated, ventilated, blood-perfused rabbit lung model, all
groups underwent lung harvest followed by 18-hour cold storage and 2-hour
blood reperfusion. Measurements of pulmonary artery pressure, lung com-
pliance, and arterial oxygenation were obtained. Group I (n = 8) served as a
control. Group II (n = 8) received gadolinium chloride at 14 mg/kg 24 hours
before lung harvest. Group III (n = 8) received leukocyte-depleted blood
reperfusion by means of a leukocyte filter.
Results: The gadolinium chloride group had significantly improved arterial
oxygenation and pulmonary artery pressure measurements compared with
control subjects and an improved arterial oxygenation compared with the fil-
ter group after 30 minutes of reperfusion. After 120 minutes of reperfusion,
however, the filter group had significantly improved arterial oxygenation and
pulmonary artery pressure measurements compared with the control group
and an improved arterial oxygenation compared with the gadolinium chlo-
ride group.
Conclusions: Lung transplant reperfusion injury occurs in two phases. The
early phase is mediated by donor pulmonary macrophages and is followed
by a late injury induced by recipient circulating leukocytes. (J Thorac
Cardiovasc Surg 2001;121:1069-75)
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Recent work with cytokine antibodies suggests that
pulmonary macrophages in donor lungs may have a
role in reperfusion injury.11 Macrophages could poten-
tially initiate reperfusion injury with further escalation
induced by circulating leukocytes. Gadolinium chlo-
ride (GdCl3), a rare lanthanide earth salt, inactivates
pulmonary macrophages by suppressing phagocytic,
immune, and inflammatory responses.17 This com-
pound has been used in recent studies to inhibit alveo-
lar macrophages.18,19 The goal of this study was to dis-
criminate between the roles of pulmonary macrophages
and circulating leukocytes in a lung model of transplant
reperfusion injury by using cell-specific inhibition with
GdCl3 and leukocyte filtration, respectively.
Materials and methods
Experimental protocol. Three experimental groups were
compared in an isolated, blood-perfused, ventilated rabbit
lung model to study lung transplant reperfusion injury.
Group I lungs (control group, n = 8) were harvested and
then stored for 18 hours at 4°C before reperfusion with
whole blood. Group II rabbits (GdCl3 group, n = 8) were
given intravenous GdCl3 (14 mg/kg; Sigma Corporation, St
Louis, Mo) 24 hours before harvest, followed by lung stor-
age for 18 hours at 4°C and reperfusion with whole blood.
Group III lungs (filter group, n = 8) underwent 18-hour stor-
age at 4°C followed by reperfusion with whole blood that
was first passed through a leukocyte-depleting filter (Pall
Purcell RCG, East Hills, NY).
Harvest procedure. Adult New Zealand White rabbits of
both sexes weighing 3.0 to 3.5 kg were randomly assigned to
the 3 experimental groups. Animals were anesthetized with
intramuscular ketamine (50 mg/kg) and xylazine (5 mg/kg).
A tracheostomy was performed, and mechanical ventilation
was instituted with a constant pressure ventilator (RSP1002;
Kent Scientific Corporation, Litchfield, Conn) by using room
air and a rate of 20 breaths/min. A median sternotomy and
thymectomy were then performed. The 2 superior and 1 infe-
rior venae cavae were loosely encircled with ligatures, and
the pericardium was opened. Both the pulmonary artery (PA)
and aorta were dissected free and similarly encircled. A
purse-string suture was placed in the free wall of the right
ventricle (RV), and intravenous heparin was administered
(500 units/kg). After injection of 30 µg of alprostadil
(prostaglandin E1; Upjohn Company, Kalamazoo, Mich) into
the PA, the cavae were interrupted and onset of ischemia was
noted. The PA was then cannulated through a right ventricu-
lotomy placed in the center of the purse-string suture. Both
the RV and PA ligatures were tied to secure the cannula. After
venting of the left ventricle (LV) with a left ventriculotomy
and ligation of the aorta, 50 mL/kg of Euro-Collins
(Hamburg, Germany) preservation solution at 4°C was
infused into the PA from a height of 30 cm. Topical cooling
was achieved with cold saline solution slush. During the PA
flush, the left atrium was cannulated through the left ven-
triculotomy with an outflow catheter and a catheter to direct-
ly transduce left atrial pressures. A purse-string suture was
placed to secure these cannulas. After completion of the PA
flush, the inflow and outflow cannulas were clamped. The
heart-lung block was excised, and the tracheostomy tube was
clamped at end-inspiration. All animals received humane care
in compliance with the “Guide for the Care and Use of
Laboratory Animals,” published by the National Institutes of
Health (NIH publication 85-23, revised 1996).
Reperfusion procedure. After organ harvest and ischemic
storage, the heart-lung block was suspended in a warm,
humidified tissue chamber and ventilation was re-established
with a 95% oxygen and 5% carbon dioxide gas mixture at a
respiratory rate of 20 breaths/min by using the constant pres-
sure ventilator (Fig 1). The inflow and outflow cannulas were
then connected to a venous blood reperfusion circuit. New
Zealand White rabbits weighing 3.5 to 5.0 kg served as fresh
venous blood donors. The lungs were reperfused with venous
blood from a main reservoir. A second nonrecirculated
venous blood reservoir was used to challenge the lungs and
determine the single pass oxygenation values during reperfu-
sion. In the experimental group designated to undergo leuko-
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Fig 1. Diagram of the isolated, blood-perfused rabbit lung model. P, Pressure transducer; N2, nitrogen gas; O2, oxy-
gen gas.
cyte-depleted reperfusion, venous blood was passed through
a leukocyte-depleting filter (Pall Purcell RCQ) before being
added to both blood reservoirs of the circuit. The circuit
(Kent Scientific Corporation) was designed to recirculate 150
mL of warmed blood by using a roller pump (7521-40; Cole
Palmer Instrument Company, Chicago, Ill) at 60 mL/min.
Continuous recordings of pulmonary artery pressure
(PAP), left atrial pressure, and air flow were performed with
a dynamic data acquisition program (Workbench PC;
Strawberry Tree, Inc, Sunnydale, Calif) on a personal com-
puter (470A; Compaq Prolinea, Houston, Tex). This program
automatically calculated and displayed tidal volume, pul-
monary vascular resistance (PVR), and dynamic airway com-
pliance. Pulmonary venous blood samples were collected for
blood gas analysis (Corning 178pH/Blood Gas Analyzer;
Corning Inc, Corning NY) after 10, 20, 30, 60, and 120 min-
utes of reperfusion. At each sampling interval, inflow from
the main reservoir was temporarily interrupted and the circuit
was filled with nonrecirculated blood from the second inflow
reservoir. A 30-mL sample of venous blood was passed
through the pulmonary vasculature at each interval to obtain
accurate measurements of pulmonary venous oxygen content.
Oxygen contact with exposed blood surfaces was minimized
by continuous passive infusion of 100% nitrogen.
Lung tissue myeloperoxidase. A myeloperoxidase assay
(MPO) was performed to quantify neutrophil sequestration.
Lung tissue was placed in 5 mL of 0.5% hexadecyltrimethyl-
ammonium bromide (HTAB) in 50 mmol/L potassium phos-
phate solution (pH 7.4) and disrupted by homogenizing at
4°C. The solution was centrifuged at 15,000g for 15 minutes
at 4°C and the supernatant was discarded. The pellet was
resuspended in 2 mL of 0.5% HTAB in 50 mmol/L potassi-
um phosphate solution (pH 6.0) and homogenized. Tissue
was disrupted further by sonication and 3 freeze-thaw cycles
(liquid nitrogen bath/37°C water bath). The solution was
again centrifuged at 15,000g for 15 minutes at 4°C. Aliquots
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Fig 2. The GdCl3 group had a significantly improved Po2 after 30 minutes of reperfusion compared with control
and filter groups. However, after 120 minutes of reperfusion, the filter group had a significantly higher Po2 com-
pared with the GdCl3 and control groups. *P < .001 GdCl3 vs all; **P < .001 Filter vs all.
Fig 3. The control group had a significantly higher PVR compared with the GdCl3 and filter groups after 30 and
120 minutes of reperfusion. There was a trend toward a lower PVR in the GdCl3 group compared with the filter
group after 30 minutes of reperfusion (P = .17). *P < .001 Control vs all; **P < .001 Control vs all.
(0.1 mL) of supernatant were added to the assay buffer of 
O-dianisdine dihydrochloride, H2O2, and 50 mmol/L potassi-
um phosphate (pH 6.0). Absorbance at 460 nm was measured
during a period of 2 minutes by spectrophotometry (LKB
model 4050, Cambridge, United Kingdom). Protein concen-
tration for each of the lung samples was measured by using
the BCA protein assay kit from Pierce (Rockford, Ill). Protein
concentrations were calculated by comparing the absorbance
at 595 nm of the experimental samples with that of known
bovine serum albumin standard concentrations in the same
assay. Lung tissue MPO activity was expressed as change in
absorbance per gram of protein per minute.
Lung wet/dry weight ratios. Lung wet/dry weight ratios
were used as a measurement of pulmonary edema. Samples
of lung tissue were weighed immediately after reperfusion.
These samples then underwent passive desiccation at room
temperature until a stable dry weight was achieved. The
weight immediately after reperfusion and the stable dry
weight were then used to calculate the lung wet/dry weight
ratios. 
Histopathology. Samples of lung tissue underwent fixation
with a 10% buffered formalin phosphate solution followed by
hematoxylin-eosin staining.
Statistical analysis. Statistical analysis was performed
with analysis of variance (ANOVA) on SPSS software (SPSS
Inc, Chicago, Ill). In addition, a repeated-measures ANOVA
was performed for data with multiple time points. Significant
differences were determined with the Bonferroni multiple
comparison test. Data are expressed as the mean ± the stan-
dard deviation.
Results
Hematologic data. White blood cell (WBC) count of
the blood reperfusate before leukocyte filtration aver-
aged 3400/µL. Leukocyte filtration substantially
reduced the WBC count of the blood reperfusate to
120/µL. The mean hematocrit value remained relative-
ly constant, with an average of 39% before filtration
and 35% after filtration. However, the average platelet
count of the blood reperfusate dropped from
112,000/µL to less than 10,000/µL after leukocyte fil-
tration. Donor rabbits in the GdCl3 group were not
noted to have any adverse events within the first 24
hours after drug treatment.
Physiologic parameters
Arterial oxygenation. Arterial PO2 was significantly
higher in the GdCl3 group (357.13 ± 126.87 mm Hg,
P < .001, Fig 2), which received the macrophage
inhibitor GdCl3, compared with the control (75.25 ±
21.34 mm Hg) and filter (leukocyte filter, 76.25 ±
20.32 mm Hg) groups after the initial 30-minute reper-
fusion period. Conversely, during the late phase (2
hours) of reperfusion, arterial Po2 was significantly
higher in the filter group (222.63 ± 43.87 mm Hg, P <
.001) than in the control (96.38 ± 42.76 mm Hg) and
GdCl3 (100.88 ± 38.80 mm Hg) groups.
PVR. Mean PVR was significantly lower in the
GdCl3 (32,262 ± 12,022 dynes · sec · cm–5, Fig 3) and
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Fig 4. Light micrograph of lung tissue from the control group
that shows severe leukocyte infiltration and edema formation
in the alveolar spaces (hematoxylin-eosin stain; original mag-
nification ×40).
Fig 5. Light micrograph of lung tissue from the GdCl3 group
that shows decreased leukocyte infiltration and edema forma-
tion in the alveolar spaces compared with the control group
(hematoxylin-eosin stain; original magnification ×40).
filter (41,558 ± 5847 dynes · sec · cm–5) groups com-
pared with control group (50,185 ± 1949 dynes · sec ·
cm–5, P = .001) at 30 minutes of reperfusion. There was
also a trend toward a lower PVR in the GdCl3 group
compared with the filter group after 30 minutes of
reperfusion (P = .17). After 120 minutes of reperfusion,
PAP was significantly lower in the GdCl3 (38,387 ±
13,205 dynes · sec · cm–5) and filter (33,176 ± 5892
dynes · sec · cm–5) groups compared with the control
group (53,025 ± 3532 dynes · sec · cm–5, P < .001).
Although the average PVR was lower in the filter group
compared with the GdCl3 group after 120 minutes of
reperfusion, the difference did not reach statistical sig-
nificance.
Dynamic airway compliance. There was a trend
toward improved airway compliance in the filter group
(1.20 ± 0.17 mL/mm Hg) compared with the control
group (1.08 ± 0.08 mL/mm Hg, P = .23) after 120 min-
utes of reperfusion. There were no significant differ-
ences in airway compliance in the GdCl3 group (1.13 ±
0.08 mL/mm Hg) compared with the filter and control
groups.
Lung wet/dry weight ratio. The mean wet/dry weight
ratio of the filter group (6.41 ± 0.91, P = .013) was sig-
nificantly lower than the wet/dry weight ratios of the
control (7.84 ± 0.76) and GdCl3 (7.50 ± 1.05) groups.
There were no significant differences in wet/dry weight
ratios between the GdCl3 and control groups.
Tissue MPO activity. There was a trend toward lower
MPO activity in the filter group (1078 ± 297
∆absorbance/g protein/min) than in the control group
(1512 ± 458 ∆absorbance/g protein/min, P = .16).
MPO activity for the GdCl3 group (1188 ± 501
∆absorbance/g protein/min) was not significantly dif-
ferent from MPO activity in control and filter groups.
In addition, in a preliminary experiment, control lungs
displayed a significant rise in tissue MPO activity
between 30 minutes and 120 minutes of whole blood
reperfusion (P = .05).
Histopathology. Control lungs (Fig 4) showed more
severe leukocyte infiltration and edema formation in
alveolar spaces after 2 hours of reperfusion compared
with the GdCl3 (Fig 5) and filter (Fig 6) groups.
Comment
During the past few years many of the cellular and
molecular events mediating the inflammatory
response to reperfusion injury have been elucidat-
ed.2,20,21 One of the critical steps responsible for
reperfusion injury is believed to be the interaction
between WBCs and the vascular endothelium during
reperfusion. Neutrophil participation in at least one
phase of reperfusion injury is established in the cur-
rent study and in work by others using various mod-
els of lung reperfusion injury.10-14 Neutrophils may
contribute to lung injury during reperfusion in sever-
al ways. One of the primary mechanisms by which
neutrophils cause injury is through the release of
toxic oxygen metabolites, such as superoxide anion,
hydroxyl radical, and hydrogen peroxide, that can
damage pulmonary endothelium directly or indirect-
ly.2 Elastase and other proteases that are products of
neutrophil granules can also directly injure pul-
monary endothelial and parenchymal cells. Finally, a
third method by which neutrophils can cause or con-
tribute to reperfusion injury is capillary plugging
(no-flow phenomenon). Activated neutrophils
become less deformable and may then be permanent-
ly trapped in alveolar capillaries, contributing to poor
reflow during reperfusion.21,22
Although many investigations in addition to the cur-
rent study have confirmed the role of neutrophils in
reperfusion injury, some have questioned neutrophil
involvement. Deeb and colleagues16 demonstrated
early on that neutrophils are not necessary to induce
reperfusion injury in an ex vivo rat lung preparation
with isolated blood cell components. Their study
reported attenuation of injury with the addition of red
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Fig 6. Light micrograph of lung tissue from the filter group
that shows decreased leukocyte infiltration and edema forma-
tion in the alveolar spaces compared with the control group
(hematoxylin-eosin stain; original magnification ×40).
blood cells or catalase. They concluded that a non-
neutrophil source of oxygen metabolites, such as lung
macrophages, was responsible for the observed
injury. Steimle and colleagues15 also demonstrated
neutrophil-independent reperfusion injury by using
neutrophil antibodies in an in vivo rat lung model at
90 minutes of reperfusion. Their study showed no
accumulation of neutrophils in the damaged lungs of
the non-neutrophil–depleted rats when compared with
the injured lungs of the neutrophil-depleted rats on the
basis of histologic and electron microscopic findings.
Eppinger and colleagues10 performed a similar in vivo
study and found that neutrophil depletion had no pro-
tective effect after 30 minutes of reperfusion but did
attenuate injury after 4 hours.
A recent investigation by Eppinger and colleagues11
strengthens the likelihood that lung macrophages are
involved in the early phase of lung reperfusion injury.
In their study the chemical mediators of reperfusion
injury in the rat lung were characterized. Tumor necro-
sis factor–alpha (TNF-α), interferon-gamma (INF-γ),
and monocyte chemoattractant protein-1 (MCP-1) were
shown to be required for early injury by using cytokine
specific antibodies. One possible mechanism for the
decreased injury with anti–TNF-α and anti–IFN-γ is
through suppression of macrophage function. Both
TNF-α and INF-γ are known to be important factors in
the respiratory burst activity and other inflammatory
functions of macrophages. They also found that
anti–MCP-1, which is an antibody against a highly spe-
cific macrophage activator and has no activity on neu-
trophils, dramatically decreased the early phase of
injury. They concluded that early lung injury is in large
part determined by products of activated macrophages,
whereas delayed injury is mediated mostly by products
of activated and recruited neutrophils.
The current study supports this bimodal concept of
reperfusion injury, consisting of both early and late
phases. At 30 minutes of reperfusion, macrophage inhi-
bition with GdCl3 significantly attenuates the poor oxy-
genation and elevated PAP measurements observed in
control lungs. This effect is substantially decreased,
however, after 120 minutes of reperfusion. For the fil-
ter group, leukocyte depletion showed no improvement
in arterial oxygenation compared with the control
group during the early phase (30 minutes) of reperfu-
sion injury. Significant improvement in oxygenation,
however, was observed in the late phase (2 hours) of
reperfusion. Tissue MPO activity tended to be lower in
the filter group than in the control group, a finding con-
sistent with depletion of circulating WBCs. If this
experiment had been performed for a longer time peri-
od, the control group likely would have had a further
increase in neutrophil sequestration, resulting in a sta-
tistically significant difference in MPO activity
between the control group and the filter group.
In a separate study combining GdCl3 and leukocyte
filtration, arterial oxygenation and PVR measurements
were similar to the GdCl3 group after 30 minutes of
reperfusion (248.71 ± 46.16 mm Hg and 31,082 ± 5434
dynes · sec · cm–5, respectively). Similarly, the com-
bined GdCl3 and leukocyte filtration group had arterial
oxygenation and PVR measurements that were similar
to the filter group after 120 minutes of reperfusion
(320.83 ± 43.70 mm Hg and 39,934 ± 8609 dynes · sec
· cm–5, respectively). In addition, our studies on MPO
in control lungs at 30 and 120 minutes showed signifi-
cantly increased MPO activity after 2 hours of reperfu-
sion compared with 30 minutes. This finding further
suggests neutrophil involvement in reperfusion injury
occurs during the late phase of reperfusion.
Most of the research in the area of lung reperfusion
injury has focused on the recipient inflammatory sys-
tem. However, activation of donor, resident alveolar
macrophages could be the initiating factor in lung dam-
age. This model would suggest that macrophages in
donor lungs are activated early on by preservation and
reperfusion. These cells subsequently release
cytokines, chemoattractants, and proteolytic enzymes
that induce an early reperfusion injury. This early dam-
age is then followed by a cascade of events leading to
activation of the recipient inflammatory system against
the already damaged lung tissue.2,11 This model of lung
reperfusion injury helps explain the early, neutrophil-
independent injury reported by some groups.
In conclusion, pulmonary reperfusion injury is a
complex process, likely involving many cell types,
cytokines, and mechanisms. Both macrophages and
neutrophils play major roles in lung injury after trans-
plantation. The effect of each cell type can be reversed
with subsequent improvement in lung function at spe-
cific time points. Macrophage inhibition with GdCl3
significantly attenuates the early (30 minutes) phase of
reperfusion injury. Leukocyte filtration with a leuko-
cyte filter significantly attenuates the late (2 hours)
phase of reperfusion. Clinical application of GdCl3,
however, is unlikely in the transplant setting because it
must be given 24 hours in advance. However, adminis-
tration of other macrophage inhibitors, such as intratra-
cheal antimacrophage antibodies, may have a potential
role in clinical lung transplantation.
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